Chesapeake Urology Physicians Named to Leadership Positions at Area Hospitals
Published On: 10/10/2017
Two Chesapeake Urology physicians have been named Chiefs of Urology at two separate Maryland hospitals. David B. Sigman, M.D., F.A.C.S., was recently named Chief of Urology at Sinai Hospital in Baltimore and Rian J. Dickstein, M.D., F.A.C.S., was named Chief of Urology at the University of Maryland Baltimore Washington Medical Center. In addition, Ryan C. Cleary, M.D., has been named Co-Director, Robotic Surgery Program, MedStar Franklin Square Medical Center.
Dr. David Sigman has been with Chesapeake Urology for more than 18 years and also serves as Chief of Urology at Northwest Hospital Center, in addition to his new appointment as Chief of Urology at Sinai Hospital. He was also a past President of the medical staff at Northwest Hospital Center and is currently a Clinical Instructor at the University of Maryland School of Medicine. Dr. Sigman's clinical interests include erectile dysfunction and prosthetic surgery, kidney stone disease including minimally invasive surgical management and prevention, benign prostate disease management and vasectomy. During his training, Dr. Sigman was awarded the A. Bradley Gaither Memorial Award for excellence in genito-urinary surgery.
Learn more about Dr. Sigman: https://www.chesapeakeurology.com/physicians/david-b-sigman-md-facs/.
Dr. Rian Dickstein is a urologic oncologist who serves as the Director of the Bladder Cancer Program at Chesapeake Urology, in addition to his recent appointment as Chief of Urology at the University of Maryland Baltimore Washington Medical Center. Dr. Dickstein also serves as the hospital’s Cancer Liaison Physician for the Tate Cancer Center as well as a Clinical Assistant Professor, Department of Surgery at University of Maryland School of Medicine. He focuses on all urologic cancers and specializes in open, laparoscopic and robotic surgeries and the treatment of bladder, kidney, prostate, testicular and penile cancers. Dr. Dickstein is a member of the Bladder Cancer Advocacy Network (BCAN) Scientific Advisory Board, which is composed of distinguished leading academic urologists, oncologists, radiation oncologists, and pathologists working within the bladder cancer field, representing many of the major cancer centers in the U.S and Canada.
Learn more about Dr. Dickstein: https://www.chesapeakeurology.com/physicians/rian-j-dickstein-md/.
Dr. Ryan Cleary joined Chesapeake Urology in 2017. A robotic surgery specialist, Dr. Cleary was recently named Co-Director, Robotic Surgery Program, MedStar Franklin Square Medical Center. He sees adult men and women for general urologic conditions, as well as focuses on urologic oncology, minimally invasive and robotic surgery, kidney tumors, hematuria, kidney stone disease, BPH, incontinence, low testosterone, overactive bladder, and erectile dysfunction. He completed a prestigious fellowship in Robotic Oncology at the Icahn School of Medicine at Mount Sinai in New York City and specializes in the minimally invasive treatment of bladder cancer, kidney cancer, prostate cancer, and adrenal tumors.
Learn more about Dr. Cleary here. https://www.chesapeakeurology.com/physicians/ryan-c-cleary-md/